Correlation between serum FGF2,ACE2 and severity of chronic obstructive pulmonary disease patients and their predictive value for prognosis
10.3969/j.issn.1673-4130.2025.02.013
- VernacularTitle:COPD患者血清FGF2、ACE2与病情严重程度的相关性及对预后的预测价值
- Author:
Juan TANG
1
;
Ji LI
;
Lei WANG
Author Information
1. 海口市人民医院医疗保健科,海南海口 570000
- Keywords:
chronic obstructive pulmonary disease;
fibroblast growth factor 2;
angiotensin converting enzyme 2;
disease condition;
prognosis
- From:
International Journal of Laboratory Medicine
2025;46(2):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the correlation between serum fibroblast growth factor 2(FGF2)and angiotensin converting enzyme 2(ACE2)levels with the severity of chronic obstructive pulmonary disease(COPD)and their predictive value for prognosis.Methods A total of 114 COPD patients treated in Hainan Cancer Hospital from June 2020 to June 2022 were selected as the study group.According to the severity of the disease,COPD patients were divided into acute exacerbation stage and stable stage.Another 114 healthy subjects were selected as control group.Serum FGF2 and ACE2 levels were detected by enzyme-linked immu-nosorbent assay.Pearson method was used to analyze the correlation between serum FGF2 and ACE2 and pul-monary function indicators.Multivariate Logistic regression was used to analyze the influencing factors of poor prognosis in COPD patients,and receiver operating characteristics(ROC)curve was plotted to analyze the predictive value of serum FGF2 and ACE2 for poor prognosis in COPD patients.Results Serum FGF2 level in the study group was significantly higher than that in the control group(P＜0.05),and serum ACE2 level,the ratio of exertional expiratory volume in the first second to predicted(FEV1％),the ratio of FEV1 to forced vi-tal capacity(FEV1/FVC),and peak expiratory flow rate(PEF)in the study group were significantly lower than those in the control group(P＜0.05).Serum FGF2 level in acute exacerbation was significantly higher than that in stable stage(P＜0.05),serum ACE2 level,FEV1％,FEV1/FVC and PEF were significantly low-er than that in stable stage(P＜0.05).Pearson correlation analysis showed that serum FGF2 and ACE2 levels were negatively correlated(P＜0.05),and serum FGF2 and ACE2 were correlated with FEV1％,FEV1/FVC and PEF(P＜0.05).The serum FGF2 level in the poor prognosis group was significantly higher than that in the good prognosis group(P＜0.05),and the serum ACE2 level was significantly lower than that in the good prognosis group(P＜0.05).Multivariate Logistic regression analysis showed that FGF2 was a risk factor for adverse prognosis in COPD patients(P＜0.05),and ACE2 was a protective factor(P＜0.05).According to ROC curve,the combination of serum FGF2 and ACE2 predicted the AUC of poor prognosis in COPD patients better than that predicted separately(Z=2.514,2.610,both P＜0.05).Conclusion Serum FGF2 level in-creased and ACE2 level decreased in COPD patients,both of which are closely related to the severity of the disease.Combined detection has certain predictive value for poor prognosis in COPD patients.
